AcuCort granted patent for the dexamethasone oral film in Brazil. The patent was issued by the INPI (Instituto Nacional da Propriedade Industrial), which is the federal authority responsible for managing the Brazilian system for granting and guaranteeing industrial property rights. The granted patent means that the oral film is given national protection in Brazil and will expire on November 4, 2035.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.74 SEK | +1.37% | +40.15% | +78.31% |
04-26 | AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | AcuCort AB Provides Update on Phase IV Study ZEQ001 | CI |
1st Jan change | Capi. | |
---|---|---|
+78.31% | 8.25M | |
-31.75% | 15.37B | |
-27.24% | 12.7B | |
-26.65% | 6.89B | |
-6.57% | 6.26B | |
+10.76% | 6.2B | |
+75.54% | 4.96B | |
-2.34% | 4.63B | |
-6.60% | 3.98B | |
-9.24% | 3.56B |
- Stock Market
- Equities
- ACUC Stock
- News AcuCort AB
- Acucort Receives Patent for Oral Film in Brazil